Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. exemption from Europe's ban on spongiform-risk materials sought by USTR.

This article was originally published in The Gray Sheet

Executive Summary

U.S. EXEMPTION FROM EUROPE'S BAN ON SPONGIFORM-RISK MATERIALS SOUGHT by the U.S. Trade Representative. USTR plans to press Europe to exempt medical devices, pharmaceuticals, cosmetics and other U.S. products from a European ban on use of materials at risk of contamination by transmissible spongiform encephalopathies (TSE). The ban, imposed by a July decision of the European Commission, is slated to go into effect Jan. 1.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel